Cancer research continues to evolve as scientists strive to unravel the complexities of tumor biology, molecular signaling, and metabolic adaptations.

An autoimmune disorder that affects the thyroid gland, called autoimmune hypothyroidism (AIHT), is the most common autoimmune disease, yet it remains largely understudied. New research from scientists ...

Academia Sinica and National Taiwan University (NTU) Hospital have jointly developed PanMETAI, an AI metabolomics platform to detect the early stages of pancreatic cancer. The tabular AI model detects ...

UT Southwestern Medical Center researchers have identified two lipids that work together with a quintessential protein known ...

In the past decade, radiomics, radiogenomics, and nanoparticle-based molecular imaging have become an important focus area of ...

The namesake award honors Dr. Harold “Hal” Weintraub, a molecular biologist who helped establish Fred Hutch’s Basic Sciences Division and died of brain cancer in 1995. Now in its 27th year, the award ...

Dr. Anczukow is a leading cancer biologist with expertise in RNA biology, molecular and cell biology, as well as human genetics, cancer biology, and genomics ...

The assay is designed to encourage informed patient-physician decision-making when choosing a treatment option in localised ...

Technologies (BMRT) today announced a transformational leap in its detection capability following six months of concentrated laboratory advancement, first-principles modeling, and controlled system ...

Members of the American Association for the Advancement of Science have elected Eric D. Isaacs, Ph.D., president of Research ...

Clinical development for both the investigational CD47-inhibitor evorpacept and the novel EGFR-targeted antibody-drug conjugate ALX2004 remains ...

Joining the call from Caris today are David Dean Halbert, our Founder, Chairman and CEO; David Spetzler, our President; Brian Brille, our Vice Chairman and EVP; Bobby Hill, our Chief Commercial ...